Replimune (REPL) Operating Leases (2018 - 2025)

Replimune has disclosed Operating Leases across 8 years of filings, most recently posting $3.7 million for Q4 2025.

• Operating Leases for Q4 2025 came in at $3.7 million, up 15.57% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.7 million (up 15.57% YoY), and the FY2025 annual result was $29.8 million, up 689.92% from the prior year.
• Operating Leases came in at $3.7 million for Q4 2025 at Replimune, down from $29.1 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $32.9 million in Q3 2021 to a low of $3.2 million in Q4 2024.
• The 5-year median for Operating Leases is $29.5 million (2025), against an average of $19.2 million.
• Across the five-year window, Operating Leases slumped 88.26% in 2024 and jumped 689.92% in 2025, its largest moves.
• Replimune's Operating Leases stood at $5.0 million in 2021, then jumped by 542.62% to $32.0 million in 2022, then plunged by 87.64% to $4.0 million in 2023, then slipped by 18.46% to $3.2 million in 2024, then advanced by 15.57% to $3.7 million in 2025.
• The last three Operating Leases figures came in at $3.7 million (Q4 2025), $29.1 million (Q3 2025), and $4.2 million (Q2 2025), per Business Quant data.